Calliditas Therapeutics to Present at Jefferies Virtual Healthcare Conference prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Aurinia Pharmaceuticals Inc. today announced that members of the executive management team will participate in a fireside chat during the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 11:30 a.m. ET. In order to participate in the audio webcast, interested parties can access the live webcast under "NewsEvents” through the “Investors” section of the Aurinia corporate website at . A replay .
KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced it will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 10:30 a.m. ET.
A live webcast of the presentation will be available on the Company s website at www.kalvista.com. An audio archive will be available on KalVista s website for 30 days following the presentations.
About KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. KalVista has developed a proprietary portfolio of novel, small molecule plasma kallikrein inhibitors initially ta
InMode to Present at the Jefferies Virtual Healthcare Conference
USA - English
Share this article
Share this article
YOKNEAM, Israel, May 27, 2021 /PRNewswire/ InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will present at the
Jefferies Virtual Healthcare Conference on June 4
th at 10:30 a.m. ET.
Yair Malca will be available for one-on-one virtual meetings during the conference. To schedule a meeting, please contact your Jefferies salesperson. A live webcast of the presentation will be available to the public at: https://inmodemd.com/investors/. The webcast will be archived for 30 days following the live presentation.
Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the